Summary
This 8-K filing from Biogen Inc. (BIIB) on February 10, 2006, details significant executive compensation adjustments and awards. Notably, the company has amended the employment agreement for CEO James C. Mullen, increasing his target bonus opportunity to 125% of his base salary and enhancing equity award vesting terms. The filing also outlines substantial long-term incentive awards, including stock options and restricted stock units, granted to Mr. Mullen and other key executive officers. These awards are designed to align executive interests with company performance and retention through multi-year vesting schedules.
Key Highlights
- 1Biogen amended CEO James C. Mullen's employment agreement, increasing his target annual cash incentive compensation to 125% of his base salary.
- 2The amendment to Mr. Mullen's employment agreement also modified equity award vesting, allowing immediate vesting of all equity awards if the company terminates his employment without cause, or due to disability/death, or if he resigns for good reason (previously only stock options had this provision).
- 3Significant long-term incentive awards were granted to CEO James C. Mullen, including stock options (240,000) and restricted stock units (80,000), with additional performance-based restricted stock units (100,000).
- 4Other executive officers received substantial grants of restricted stock units (approximately 147,900 total) and stock options (approximately 369,500 total) under the 2005 Omnibus Equity Plan.
- 5The filing details updated 2006 base salaries for executive officers, with CEO James C. Mullen's base salary increasing to $1,100,000 from $1,000,000.
- 62005 cash bonuses for executive officers were disclosed, with CEO James C. Mullen receiving $1,200,000.
- 7The Non-Executive Chairman of the Board, Bruce R. Ross, will receive a $200,000 cash retainer for the six months ending June 30, 2006, in addition to his existing director compensation.
Frequently Asked Questions
The primary changes involve an amendment to his employment agreement. His target bonus opportunity was increased to 125% of his base salary. Additionally, the conditions for immediate vesting of equity awards were expanded to cover all equity awards (not just stock options) in cases of termination without cause, death, disability, or resignation for good reason.
Executives received stock options and restricted stock units (RSUs). Stock options generally vest over four years (25% per year). RSUs also generally vest over three years (33 1/3% per year). A portion of CEO Mullen's RSUs are performance-based and vest based on specific criteria and continued employment.
The company has established 2006 corporate performance goals, including revenue and EPS growth, performance of specific business units, business development, R&D milestones, and manufacturing capabilities. Individual performance goals are also set. Actual bonuses are determined based on a formula incorporating these corporate and individual goals, with payments expected in March 2007.
Yes, the Non-Executive Chairman of the Board, Bruce R. Ross, will receive a $200,000 cash retainer for the six-month period ending June 30, 2006. Additionally, outside directors will receive a fee of $1,000 for each full day of service rendered in their directorial duties, excluding regular board or committee meetings.